Milly Wickson

Solicitor, Bristows

Milly is an associate in the Patent Litigation team at Bristows. She advises on a wide range of issues across the life sciences and technology sectors, but has a particular interest in pharmaceuticals. Recent experience includes UK litigation in the small molecule and biologics spaces, supporting oppositions at the European Patent Office and giving freedom to operate advice on medical and consumer devices.

Milly has also assisted with multi-jurisdiction coordination projects and gained commercial experience working at a leading pharmaceuticals company.

Contributed to

2

Second and subsequent medical use patent claims

Practice Notes

This Practice Note examines the two different types of second medical use claims (purpose-limited process ‘Swiss-form’ claims and purpose-limited product ‘EPC 2000’ claims), the differences between them and their enforcement in England and Wales. It also discusses the impact of the Supreme Court judgment in Warner-Lambert v Generics (UK) and Actavis.

Life Sciences

The experimental use and Bolar-type exemptions to patent infringement

Practice Notes

This Practice Note examines the two principal research exemptions to patent infringement available under UK law, namely, the general experimental use exemption (sometime referred to as the experimental use defence) and the specific ‘Bolar-type’ exemption. It discusses what is required in order to benefit from these exceptions to infringement under section 60(5) and (6) of the Patents Act 1977 (PA 1977) and practical considerations, eg how to deal with suppliers in contracts and research tools. This Practice Note also discusses the supplementary protection certificate (SPC) manufacturing waiver which provides an exception to infringement of SPCs.

Life Sciences